Start-up of the week: Inflection Biosciences

The figures around cancer are terrifying. In Ireland, it is the second most common cause of death, and one in three people will develop it in their lifetime.

Darren Cunningham and Michael O'Neill, co-founders of Inflection Biosciences. Photo: Keith Arkins